Neuren Pharma Director Ups Shareholding
Company Announcements

Neuren Pharma Director Ups Shareholding

Neuren Pharmaceuticals Limited (AU:NEU) has released an update.

Neuren Pharmaceuticals Limited has disclosed a change in the interest of their Director, Joseph Basile, who has increased his stake in the company. On June 11, 2024, Basile purchased an additional 5,000 ordinary shares via an on-market trade for a total consideration of $97,450, or $19.49 per share, raising his total holdings to 15,000 shares. This financial activity was reported in compliance with ASX listing rule 3.19A.2.

For further insights into AU:NEU stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Australian Auto-Generated NewsdeskNeuren Pharmaceuticals Sees Surge in H1 Revenue
TipRanks Australian Auto-Generated NewsdeskNeuren Pharmaceuticals Posts Sharp Profit Decline
TipRanks Australian Auto-Generated NewsdeskNeuren Aims to Transform Neurodevelopmental Care
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App